Our experimental studies demonstrate antiproliferative effects of CHRNA5 depletion in breast cancer cell lines using multiple approaches, i.e., RT-qPCR, Western blotting, and comparative transcriptomics analyses. This evidence concerns the gene CHRNA5 and breast cancer.